Dr. rer. nat. Simon Völkl

Department of Medicine 5 – Haematology and Oncology

Human Double-Negative Regulatory T-Cells Induce a Metabolic and Functional Switch in Effector T-Cells by Suppressing mTOR Activity (2019) Haug T, Aigner M, Peuser MM, Strobl C, Hildner K, Mougiakakos D, Bruns H, et al. Journal article Deficiency of Fhl2 leads to delayed neuronal cell migration and premature astrocyte differentiation (2019) Kim SY, Ludwig S, Schneider H, Wixler V, Park J, Völkl S Journal article Specific inhibition of PRMT5 suppresses human CD8+T cells by upregulation of p53 and impairment of the AKT pathway similar to the tumor metabolite MTA (2019) Strobl C, Schaffer S, Haug T, Peter K, Böttcher M, Mougiakakos D, Mackensen A, et al. Conference contribution Bone marrow stroma cells promote a S100A8/A9high subset of chemoresistant AML blasts with distinct metabolic features in a Jak/STAT-dependent manner (2019) Böttcher M, Panagiotidis K, Mentz K, Bruns H, Mackensen A, Mougiakakos D, Völkl S Conference contribution The oncometabolite 5 '-methylthioadenosine (MTA) blocks NK cell functions early after activation (2019) Jacobs B, Schlögl S, Mougiakakos D, Mackensen A, Aigner M, Völkl S Conference contribution Oxidative stress upon allogeneic hematopoietic stem cell transplantation and its impact on the reconstituting immune system (2019) Karl F, Böttcher-Loschinski R, Stoll A, Rösler W, Mackensen A, Mougiakakos D, Völkl S Conference contribution Effect of Proinflammatory and Homeostatic Cytokines on the Functionality of Human Double-Negative Regulatory T Cells (2018) Peuser M, Haug T, Aigner M, Mackensen A, Völkl S Conference contribution Bacterial nanocellulose stimulates mesenchymal stem cell expansion, differentiation and formation of stable collagen-I networks (2018) Vielreicher M, Kralisch D, Völkl S, Friedrich O Conference contribution, Abstract of a poster Intestinal graft-versus-host disease is driven by BATF-dependent IL-7R(hi)GM-CSF+ T cells (2018) Ullrich E, Abendroth B, Rothamer J, Huber C, Buettner-Herold M, Kitowski V, Vogler T, et al. Conference contribution CD33/CD3-bispecific T-cell engaging (BiTE®) antibody construct targets monocytic AML myeloid-derived suppressor cells (2018) Jitschin R, Saul D, Braun M, Tohumeken S, Kischel R, Lutteropp M, Dos Santos C, et al. Journal article